GJGuojia Jiang

Guojia Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guojia Jiang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Danni Xu

    Shanghai University of Traditional Chinese Medicine, School of Public Health, Shanghai, China

    1 shared publication
  • Deji Song

    Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Institute of Digestive Diseases, Shanghai, China

    1 shared publication
  • Guang Ji

    Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, China

    1 shared publication
  • Hailei Zhao

    Shanghai University of Traditional Chinese Medicine, School of Public Health, Shanghai, China

    1 shared publication
  • Jiayun Feng

    Shanghai University of Traditional Chinese Medicine, School of Public Health, Shanghai, China

    1 shared publication
  • Jolaoluwa Grace Oparinde

    Shanghai University of Traditional Chinese Medicine, School of Public Health, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Global surge in pancreatic cancer cases driven by ageing populations and modifiable risks

    by Wanyi Zheng, Guojia Jiang, Jolaoluwa Grace Oparinde, Ziqi Zhang, Deji Song, Yi Ding, Jiayun Feng, Youyan Xu, Danni Xu, Hailei Zhao, et al.

    Pancreatic cancer (PC) ranks among the most lethal malignant neoplasms, primarily due to its late-stage diagnosis and lack of available therapeutic modalities. This study aimed to characterise the current PC epidemiological profiles, lifestyle-related contributors, and projections to unveil its global disease burden. Using 2022 data from the Global Cancer Observatory (GCO), we estimated PC incidence, mortality, 5-year prevalence, and mortality-incidence-ratio. Modifiable risk factors were extracted from the Global Health Observatory to identify its predictive model. The temporal trends were assessed via estimated annual percentage changes (EAPCs) stratified by age and gender, and the future projection was also collected from GCO, 2022–2050, estimated number of new cases and deaths data. In 2022, Northern America and Europe had the highest PC burden, with males consistently affected more than females. Alarmingly, a concerning increase in PC mortality was observed among older females. Projections indicate an 85–91% increase in elderly PC cases by 2050, with Asia facing the greatest challenge (487 087 estimated new cases) and Africa being estimated with the fastest mortality growth (159.2%). Strong positive correlations were observed between PC prevalence and human development index (HDI), as well as lifestyle factors e.g. raised total cholesterol (correlation coefficient (r) = 0.695, P < 0.001), cigarette smoking (r = 0.528, P < 0.001), and alcohol drinking (r = 0.505, P < 0.001). This research underlines the urgent need for region-specific interventions, not only for Northern America and Europe, which currently bear a high PC burden, but also for high-risk populations like Asia and Africa. The projected 85–91% rise in elderly PC cases by 2050, coupled with emerging risks in young females (incidence rose in n/N = 39/52 countries), demands prioritised research on modifiable factors and sex-tailored prevention strategies. These discoveries call for global action to mitigate the escalating PC burden through demographic-targeted public health measures.